Stay updated on SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial
Sign up to get notified when there's something new on the SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial page.

Latest updates to the SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a clinical trial for SAGE-547 in treating Super-Refractory Status Epilepticus, including inclusion and exclusion criteria, and the principal investigators' names. A new version number has been added.SummaryDifference12%
- Check18 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check26 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check62 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check76 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
- Check84 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial page.